Regina Salvat - Profile and Investment Details

Investor Profile

Regina Salvat is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics, Amplyx Pharmaceuticals, Marea Therapeutics, Sorbent Therapeutics, Visen Pharmaceuticals, VersartisVerdiva Bio, Auris Medical, Aerovate Therapeutics, Medeor Therapeutics, Alkeus Pharmaceuticals, Inc., Guavus, Edge Therapeutics, NorthSea Therapeutics, Athira Pharma, Ascendis Pharma, Audentes Therapeutics, CinCor Pharma, Karuna Therapeutics, BIOAGE LABS, Bolt Biotherapeutics, Vestagen Technical Textiles, InCarda Therapeutics, Ziarco, Pionyr Immunotherapeutics, Expedition Therapeutics, Invitae, AFYX Therapeutics, XyloCor Therapeutics, Natera, LYSOGENE, Neurana Pharmaceuticals, Kiniksa Pharmaceuticals, Aeovian Pharmaceuticals, Principia Biopharma, Innocoll Holdings, Quanta Therapeutics, NuCana BioMed, ZS Pharma, NextCure, Aerovate Therapeutics, Inc., ConteXtream, Chiasma, OnCusp Therapeutics, Aclaris Therapeutics, Vera Therapeutics, Checkmate Pharmaceuticals, First Aid Shot Therapy, Apellis Pharmaceuticals, McPhy, Civitas Therapeutics, Crocus Technology, Atsena Therapeutics, Rainier Therapeutics, Rubius Therapeutics, Galera Therapeutics, Gyroscope Therapeutics, VelosBio, Antiva Biosciences, Intrepida Bio, Merus, Mirna Therapeutics, Akouos, Coherus Biosciences, CinCor Pharma, Inc., aTyr Pharma, Bolt Biotherapeutics, Inc., Inozyme, Promedior, Iterum Therapeutics, ObsEva, Dauntless Pharmaceuticals, Spark Therapeutics, Entasis Therapeutics, . Over time, Regina Salvat has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Regina Salvat is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Genetics, Autoimmune Diseases, Wellness, Women Founded, Immunotherapy, Rare Diseases, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Finance, Bioinformatics, Biotechnology, Consumer Health, Medical Devices, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Precision Medicine, Environmental Technology, Neuropsychiatric Disorders, Clinical Trials, Capital Raising, Gene Therapy, Digital Health, Regulatory Compliance, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Regina Salvat, as their portfolio suggests a familiarity and interest in this area.

Understanding Regina Salvat’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.